OrbiMed’s Avalo Therapeutics AVTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$4.83M	Hold	967,000	–	–	0.12%	76
2025 Q1	$7.75M	Hold	967,000	–	–	0.18%	67
2024 Q4	$7.18M	Hold	967,000	–	–	0.15%	74
2024 Q3	$9.19M	Buy	+967,000	New	+$9.19M	0.17%	80